Lumateperone

(Caplyta)

Lumateperone

Drug updated on 11/14/2023

Dosage FormCapsule (oral; 42 mg)
Drug ClassAtypical antipsychotics
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of schizophrenia in adults.
  • For the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults, as monotherapy and as adjunctive therapy with lithium or valproate.